Kawasaki, Japan

Junko Takashima

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Chemical Industries Limited. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junko Takashima. Retrieved from https://idiyas.com/inventor/junko-takashima-h7pgixms

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junko Takashima: Innovator in Corticoid Research

Introduction

Junko Takashima is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel corticoid compounds. Her work focuses on creating effective treatments with minimal side effects.

Latest Patents

Junko Takashima holds a patent for "6-oxygenated corticoid 17.alpha.-carbonates and process for production." This innovative patent describes compounds that exhibit strong topical anti-inflammatory activity while causing extremely weak systemic adverse reactions. These compounds are particularly useful in treating various conditions, including acute and chronic eczema, seborrheic eczema, contact dermatitis, atopic dermatitis, and asthma.

Career Highlights

Throughout her career, Junko has been associated with Mitsubishi Chemical Industries Limited, where she has been able to apply her expertise in pharmaceutical research. Her dedication to innovation has led to advancements in the treatment of inflammatory skin conditions.

Collaborations

Junko has collaborated with notable colleagues, including Issei Nitta and Kenichiro Nakao, to further her research and development efforts. Their combined expertise has contributed to the success of their projects.

Conclusion

Junko Takashima's work in the field of corticoids exemplifies her commitment to improving healthcare through innovative solutions. Her contributions continue to impact the treatment of inflammatory conditions positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…